CAR T-Cell Therapy for Patients with Multiple Myeloma: Current Evidence and Challenges
{{output}}
The therapeutic landscape of multiple myeloma (MM) has benefited from an emergence of novel therapies over the last decade. By inducing T-cell kill of target cancer cells, chimeric antigen receptor (CAR) T-cell therapies have improved outcomes of patients with... ...
